Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8601)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 7, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Urbanik T, Koehler BC, Wolpert L, Elßner C, Scherr AL, Longerich T, Kautz N, Welte S, Hövelmeyer N, Jäger D, Waisman A, Schulze-Bergkamen H. CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes. World J Gastroenterol 2014; 20(45): 17049-17064 [PMID: 25493017 DOI: 10.3748/wjg.v20.i45.17049] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17049.htm |
| Number | Citing Articles |
| 1 |
Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, Beate K. Straub, Julia Weinmann-Menke, Marcus A. Wörns, Peter R. Galle, Jörn M. Schattenberg. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. Journal of Hepatology 2018; 68(5): 986 doi: 10.1016/j.jhep.2018.01.008
|
| 2 |
Amir Sadra Zangouei, Meysam Moghbeli. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes and Environment 2021; 43(1) doi: 10.1186/s41021-021-00192-4
|
| 3 |
Nadine Gehrke, Marcus A. Wörns, Amrit Mann, Nadine Hövelmeyer, Ari Waisman, Beate K. Straub, Peter R. Galle, Jörn M. Schattenberg. Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure. Cell Death & Disease 2022; 13(5) doi: 10.1038/s41419-022-04946-y
|
| 4 |
Ji Cheng, Jianping Guo, Brian J. North, Bin Wang, Chun-Ping Cui, Hongchang Li, Kaixiong Tao, Lingqiang Zhang, Wenyi Wei. Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1872(2): 188312 doi: 10.1016/j.bbcan.2019.188312
|
| 5 |
Xiaoxi Liu, Laura Doherty, Alejandra Felix, Sara Buhrlage. Protein Homeostasis in Drug Discovery. 2022; : 249 doi: 10.1002/9781119774198.ch7
|
| 6 |
Nikolaos Bekas, Martina Samiotaki, Maria Papathanasiou, Panagiotis Mokos, Athanasios Pseftogas, Konstantinos Xanthopoulos, Dimitris Thanos, George Mosialos, Dimitra Dafou. Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency. Cancers 2023; 15(20): 4997 doi: 10.3390/cancers15204997
|
| 7 |
Elham Aryapour, Thomas Kietzmann. Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology. Journal of Cellular Biochemistry 2022; 123(10): 1634 doi: 10.1002/jcb.30312
|
| 8 |
Yanhui Li, Wei Huang, Youhua Xu, Luping Zhou, Yaling Liang, Chenlin Gao, Yang Long, Yong Xu. CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-κB Inflammatory Signaling in Mesangial Cells. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/3982906
|
| 9 |
Claus Hellerbrand, Ramin Massoumi. Cylindromatosis—A Protective Molecule against Liver Diseases. Medicinal Research Reviews 2016; 36(2): 342 doi: 10.1002/med.21381
|
| 10 |
Guangying Zhou, Shasha Wang. YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling. Applied Biochemistry and Biotechnology 2024; 196(1): 588 doi: 10.1007/s12010-023-04540-8
|
| 11 |
Lei Yin, Shuai Liu, Chensheng Li, Sentai Ding, Dongbin Bi, Zhihong Niu, Liping Han, Wenjia Li, Dexuan Gao, Zheng Liu, Jiaju Lu. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated. Tumor Biology 2016; 37(9): 12731 doi: 10.1007/s13277-016-5157-0
|
| 12 |
Liang Xu, Yu Jia, Xiang-Hong Yang, Fang Han, Yang Zheng, Yin Ni, Xu Chen, Jun Hong, Jing-Quan Liu, Qian Li, Ren-Hua Sun, Shi-Jing Mo. MicroRNA-130b transcriptionally regulated by histone H3 deacetylation renders Akt ubiquitination and apoptosis resistance to 6-OHDA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(6): 1678 doi: 10.1016/j.bbadis.2017.04.012
|
| 13 |
Michal Wozniak, Malgorzata Czyz. The Functional Role of Long Non-Coding RNAs in Melanoma. Cancers 2021; 13(19): 4848 doi: 10.3390/cancers13194848
|
| 14 |
Zhangding Wang, Qiang Wang, Guifang Xu, Na Meng, Xinli Huang, Zerun Jiang, Chen Chen, Yan Zhang, Junjie Chen, Aiping Li, Nan Li, Xiaoping Zou, Jianwei Zhou, Qingqing Ding, Shouyu Wang. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells. RNA Biology 2020; 17(11): 1576 doi: 10.1080/15476286.2019.1709296
|
| 15 |
Si Ying Tang, Ying Xu, Cong Cong Jiao, Meng Hui Jiang, Nan Kong, Hao Ding, Lian Hua Cui, Jin-Mei Piao. Clinical significance of cylindromatosis expression in primary hepatocellular carcinoma. Arab Journal of Gastroenterology 2023; 24(1): 58 doi: 10.1016/j.ajg.2022.11.001
|
| 16 |
Jianwen Long, Xianming Pi. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/2086564
|